BioRestorative Therapies annual gross margin
2012
2013
2014
2015
2016
2017
2023
2024
2025
BioRestorative Therapies Gross Margin Growth & History (BRTX)
BioRestorative Therapies's gross margin was 93.37% for fiscal 2025.
View full BioRestorative Therapies company overviewBioRestorative Therapies annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 93.37% | +0.37 pp |
| 2024 | 2024-12-31 | 93.00% | −7.00 pp |
| 2023 | 2023-12-31 | 100.00% | 0.00 pp |
| 2017 | 2017-12-31 | 100.00% | +0.28 pp |
| 2016 | 2016-12-31 | 99.72% | +41.30 pp |
| 2015 | 2015-12-31 | 58.42% | +9.82 pp |
| 2014 | 2014-12-31 | 48.60% | −39.02 pp |
| 2013 | 2013-12-31 | 87.62% | −4.00 pp |
| 2012 | 2012-12-31 | 91.62% | — |
BioRestorative Therapies quarterly gross margin
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q1 2026 | 2026-03-31 | 68.13% | −20.24 pp |
| Q4 2025 | 2025-12-31 | 91.65% | −0.64 pp |
| Q3 2025 | 2025-09-30 | 10.42% | −81.77 pp |
| Q2 2025 | 2025-06-30 | 97.12% | +4.41 pp |
| Q1 2025 | 2025-03-31 | 88.36% | −11.64 pp |
| Q4 2024 | 2024-12-31 | 92.29% | −7.71 pp |
| Q3 2024 | 2024-09-30 | 92.19% | −7.81 pp |
| Q2 2024 | 2024-06-30 | 92.72% | −7.28 pp |
| Q1 2024 | 2024-03-31 | 100.00% | 0.00 pp |
| Q3 2023 | 2023-09-30 | 100.00% | 0.00 pp |
| Q2 2023 | 2023-06-30 | 100.00% | 0.00 pp |
| Q4 2017 | 2017-12-31 | 100.00% | +0.35 pp |
| Q3 2017 | 2017-09-30 | 100.00% | 0.00 pp |
| Q2 2017 | 2017-06-30 | 100.00% | +0.44 pp |
| Q1 2017 | 2017-03-31 | 100.00% | +0.11 pp |
| Q4 2016 | 2016-12-31 | 99.65% | +29.54 pp |
| Q3 2016 | 2016-09-30 | 100.00% | +52.98 pp |
| Q2 2016 | 2016-06-30 | 99.56% | +49.74 pp |
| Q1 2016 | 2016-03-31 | 99.89% | +41.23 pp |
| Q4 2015 | 2015-12-31 | 70.12% | +102.15 pp |
| Q3 2015 | 2015-09-30 | 47.02% | −11.64 pp |
| Q2 2015 | 2015-06-30 | 49.82% | −26.10 pp |
| Q1 2015 | 2015-03-31 | 58.66% | −25.34 pp |
| Q4 2014 | 2014-12-31 | −32.03% | −124.03 pp |
| Q3 2014 | 2014-09-30 | 58.66% | −32.87 pp |
| Q2 2014 | 2014-06-30 | 75.92% | −9.74 pp |
| Q1 2014 | 2014-03-31 | 84.00% | −5.84 pp |
| Q3 2013 | 2013-09-30 | 92.00% | +16.31 pp |
| Q2 2013 | 2013-06-30 | 91.53% | −8.47 pp |
| Q1 2013 | 2013-03-31 | 85.66% | — |
| Q4 2012 | 2012-12-31 | 89.84% | — |
| Q3 2012 | 2012-09-30 | 75.69% | — |
| Q2 2012 | 2012-06-30 | 100.00% | — |
BioRestorative Therapies gross margin trends
Over the last five reported fiscal years, BioRestorative Therapies's gross margin increased from 58.42% to 93.37%, a change of +34.95 percentage points. The latest reported quarter, Q1 2026, shows 68.13%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BioRestorative Therapies filings at SEC.gov ↗